$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Pharmacokinetics and pharmacodynamics of oral cephalosporins as critical factors in choice of antibiotics

International journal of antimicrobial agents, v.16 no.4, 2000년, pp.501 - 505  

Novelli, A. (Corresponding author: Tel.: +39-055-4271 ext. 310) ,  Fallani, S. (fax: +39-055-4271 ext. 280) ,  Cassetta, M.I. (Dipartimento di Farmacologia Preclinica e Clinica, Università) ,  Conti., S. (degli Studi, Viale Pieraccini, 6–)

초록이 없습니다.

주제어

참고문헌 (43)

  1. Diagn. Microbiol. Infect. Dis. Craig 22 89 1995 10.1016/0732-8893(95)00053-D Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins 

  2. Clin. Infect. Dis. Craig 26 1 1998 10.1086/516284 Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men 

  3. DICP Ann. Pharmacother. Zhanel 25 153 1991 The postantibiotic effect: a review of in vitro and in vivo data 

  4. Scand. J. Infect. Dis. Suppl. Hanberger 74 118 1990 Pharmacodynamics of beta-lactam antibiotics on Gram-negative bacteria: initial killing, morphology and postantibiotic effect 

  5. Eur. J. Clin. Microbiol. Infect. Dis. Hanberger 10 927 1991 10.1007/BF02005446 Post-antibiotic effect of beta-lactam antibiotics on gram-negative bacteria in relation to morphology, initial killing and MIC 

  6. Craig 403 1991 Antibiotics in Laboratory Medicine Postantibiotic effect 

  7. Antimicrob. Agents Chemother. Libby 42 78 1998 10.1128/AAC.42.1.78 Postantibiotic effect in Escherichia coli determined with real-time metabolic monitoring 

  8. Antimicrob. Agents Chemother. Odenholt 41 2522 1997 10.1128/AAC.41.11.2522 Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase 

  9. J. Antimicrob. Chemother. Kumar 30 597 1992 10.1093/jac/30.5.597 Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia 

  10. Farmaci & Terapia Novelli 14 1 1997 Effetto post-antibiotico in vitro di β-lattamine orali 

  11. Periti 1988 Attualita delle cefalosporine in chemioterapia 

  12. Mayo Clin. Proc. Marshall 74 187 1999 10.4065/74.2.187 The cephalosporins 

  13. Le infezioni in Medicina Russo 4 Suppl. 1 3 1996 Aspetti microbiologici e farmacologici clinici del cefacloro e di una nuova preparazione farmaceutica: il cefacloro a rilascio modificato 

  14. Drugs Perry 52 125 1996 10.2165/00003495-199652010-00009 Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy 

  15. Drugs Wiseman 45 295 1993 10.2165/00003495-199345020-00008 Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential 

  16. Drugs Lode 47 Suppl. 3 10 1994 10.2165/00003495-199400473-00004 Comparative pharmacokinetics of the new oral cephalosporins 

  17. Clin. Pharmacokinet. Klepser 28 5 361 1995 10.2165/00003088-199528050-00003 Clinical pharmacokinetics of newer cephalosporins 

  18. Drugs Bryson 45 589 1993 10.2165/00003495-199345040-00009 Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use 

  19. Drugs Frampton 44 889 1992 10.2165/00003495-199244050-00011 Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential 

  20. Drugs Markham 49 1007 1995 10.2165/00003495-199549060-00010 Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections 

  21. Scand. J. Infect. Dis. Suppl. Eden 39 48 1983 Penetration of cefaclor to adenoid tissue and middle ear fluid in secretory otitis media 

  22. J. Antimicrob. Chemother. Gehanno 26 Suppl E 47 1990 10.1093/jac/26.suppl_E.47 Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil 

  23. Int. J. Clin. Pharmacol. Res. Jetlund 11 1 1 1991 Comparison of the serum and tissue concentrations of cefuroxime from cefuroxime axetil and phenoxymethylpenicillin in patients undergoing tonsillectomy 

  24. Clin. Pharmacokinet. Blouin 25 172 1993 10.2165/00003088-199325030-00002 Cefetamet pivoxil clinical pharmacokinetics 

  25. Eur. J. Clin. Microbiol. Infect. Dis. Scaglione 15 940 1996 10.1007/BF01690513 Ceftibuten concentrations in human tonsillar tissue 

  26. Pathol. Biol. (Paris) Begue 37 433 1989 Tonsil diffusion of cefixime in children 

  27. Antimicrob. Agents Chemother. Shyu 37 1180 1993 10.1128/AAC.37.5.1180 Penetration of cefprozil into tonsillar and adenoidal tissues 

  28. Antimicrob. Agents Chemother. Shyu 38 2210 1994 10.1128/AAC.38.9.2210 Penetration of cefprozil into middle ear fluid of patients with otitis media 

  29. Acta Otolaryngol. Suppl. (Stockh.) Ernstson 424 7 1985 10.3109/00016488509121604 Penetration of cefaclor to adenoid tissue and middle ear effusion in chronic OME 

  30. Pediatr. Infect. Dis. J. Haddad 10 294 1991 10.1097/00006454-199104000-00006 Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil 

  31. Antimicrob. Agents Chemother. Nix 35 1947 1991 10.1128/AAC.35.10.1947 Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning 

  32. Ann. Ital. Med. Int. Mazzei 7 Suppl. 3 67 1992 Concentrazioni plasmatiche e tissutali degli antibiotici: qual e il loro valore predittivo? 

  33. Antimicrob. Agents Chemother. Barry 38 2419 1994 10.1128/AAC.38.10.2419 In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993 

  34. Antimicrob. Agents Chemother. Jacobs 43 1901 1999 10.1128/AAC.43.8.1901 Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study 

  35. Antimicrob. Agents Chemother. Nash 35 192 1991 10.1128/AAC.35.1.192 Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae 

  36. GIMMOC Nicoletti 3 25 1999 Speciale A. Osservatorio epdiemiologico italiano. Patogeni batterici respiratori comunitari e nosocomiali:analisi delle resistenze nel 1997. Haemophilus influenzae, Haemophilus parainfluenzae e Moraxella catarrhalis 

  37. GIMMOC Schito 3 11 1999 Osservatorio epidemiologico italiano. Patogeni batterici respiratori comunitari e nosocomiali:analisi delle resistenze nel 1997. Streptococcus pneumoniae 

  38. J. Antimicrob. Chemother. Spangler 31 273 1993 10.1093/jac/31.2.273 Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829 

  39. Antimicrob. Agents Chemother. Fung-Tomc 39 533 1995 10.1128/AAC.39.2.533 Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides 

  40. Antimicrob. Agents Chemother. Fitoussi 39 2560 1995 10.1128/AAC.39.11.2560 Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile 

  41. Antimicrob. Agents Chemother. Manduru 41 2053 1997 10.1128/AAC.41.9.2053 In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients 

  42. Antimicrob. Agents Chemother. Cappelletty 40 1148 1996 10.1128/AAC.40.5.1148 Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model 

  43. Antimicrob. Agents Chemother. Powell 35 2042 1991 10.1128/AAC.35.10.2042 Pharmacokinetics of cefuroxime axetil suspension in infants and children 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로